DIFFUSE MIDLINE GLIOMA
Clinical trials for DIFFUSE MIDLINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE MIDLINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells injected directly into the brain show promise for childhood cancers
Disease control Recruiting nowThis early-stage study is testing whether specially engineered immune cells (CAR T cells) can be safely given directly into the brain or spinal fluid of children and young adults with aggressive brain tumors like DIPG or recurrent medulloblastoma. The cells are designed to recogn…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Global effort to unlock secrets of rare childhood brain tumors
Knowledge-focused Recruiting nowThis study creates a worldwide database of medical information and tumor samples from people with DIPG or DMG, rare and aggressive brain tumors. Researchers aim to learn how these tumors work at a molecular level to help design better treatments in the future. Anyone diagnosed wi…
Matched conditions: DIFFUSE MIDLINE GLIOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC